Health-related quality of life of patients with chronic myeloid leukemia as measured by patient-reported outcomes: current state and future directions

KL Schoenbeck, KE Flynn - Current hematologic malignancy reports - Springer
Abstract Purpose of Review Tyrosine kinase inhibitors (TKIs) allow many patients with
chronic myeloid leukemia (CML) to live normal life spans but have the potential to impact …

Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions.

KL Schoenbeck, KE Flynn - Current Hematologic Malignancy …, 2021 - europepmc.org
Tyrosine kinase inhibitors (TKIs) allow many patients with chronic myeloid leukemia (CML)
to live normal life spans but have the potential to impact patients' health-related quality of life …

Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions

KL Schoenbeck, KE Flynn - Current hematologic …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose of review Tyrosine kinase inhibitors (TKIs) allow many patients with chronic myeloid
leukemia (CML) to live normal life spans but have the potential to impact patients' health …